Literature DB >> 8287343

Risks and probabilities of breast cancer: short-term versus lifetime probabilities.

H E Bryant1, P M Brasher.   

Abstract

OBJECTIVE: To calculate age-specific short-term and lifetime probabilities of breast cancer among a cohort of Canadian women.
DESIGN: Double decrement life table.
SETTING: Alberta.
SUBJECTS: Women with first invasive breast cancers registered with the Alberta Cancer Registry between 1985 and 1987. MAIN OUTCOME MEASURES: Lifetime probability of breast cancer from birth and for women at various ages; short-term (up to 10 years) probability of breast cancer for women at various ages.
RESULTS: The lifetime probability of breast cancer is 10.17% at birth and peaks at 10.34% at age 25 years, after which it decreases owing to a decline in the number of years over which breast cancer risk will be experienced. However, the probability of manifesting breast cancer in the next year increases steadily from the age of 30 onward, reaching 0.36% at 85 years. The probability of manifesting the disease within the next 10 years peaks at 2.97% at age 70 and decreases thereafter, again owing to declining probabilities of surviving the interval.
CONCLUSIONS: Given that the incidence of breast cancer among Albertan women during the study period was similar to the national average, we conclude that currently more than 1 in 10 women in Canada can expect to have breast cancer at some point during their life. However, risk varies considerably over a woman's lifetime, with most risk concentrated after age 49. On the basis of the shorter-term age-specific risks that we present, the clinician can put breast cancer risk into perspective for younger women and heighten awareness among women aged 50 years or more.

Entities:  

Mesh:

Year:  1994        PMID: 8287343      PMCID: PMC1486211     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  17 in total

1.  Health care and health status. A Canada--United States statistical comparison.

Authors:  C Nair; R Karim; C Nyers
Journal:  Health Rep       Date:  1992       Impact factor: 4.796

2.  The probability of developing cancer.

Authors:  R E CASHMAN; P R GERHARDT; I D GOLDBERG; V H HANDY; M L LEVIN
Journal:  J Natl Cancer Inst       Date:  1956-08       Impact factor: 13.506

3.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

4.  The probability of developing cancer.

Authors:  M S Zdeb
Journal:  Am J Epidemiol       Date:  1977-07       Impact factor: 4.897

5.  The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.

Authors:  L Tabar; G Fagerberg; S W Duffy; N E Day
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

6.  The lifetime risk of developing breast cancer.

Authors:  E J Feuer; L M Wun; C C Boring; W D Flanders; M J Timmel; T Tong
Journal:  J Natl Cancer Inst       Date:  1993-06-02       Impact factor: 13.506

7.  Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial.

Authors:  J Frisell; G Eklund; L Hellström; E Lidbrink; L E Rutqvist; A Somell
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872

8.  Age as a factor in breast cancer knowledge, attitudes and screening behaviour.

Authors:  Z Mah; H Bryant
Journal:  CMAJ       Date:  1992-06-15       Impact factor: 8.262

9.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

10.  Probabilities of eventually developing or dying of cancer--United States, 1985.

Authors:  H Seidman; M H Mushinski; S K Gelb; E Silverberg
Journal:  CA Cancer J Clin       Date:  1985 Jan-Feb       Impact factor: 508.702

View more
  10 in total

1.  Does raloxifene reduce postmenopausal women's risk of breast cancer?

Authors:  R K Han; N Pimlott; R Heisey
Journal:  Can Fam Physician       Date:  2000-01       Impact factor: 3.275

Review 2.  Should family physicians be teaching and encouraging women to perform regular breast self-examination?

Authors:  R Heisey; N Pimlott; M F Evans
Journal:  Can Fam Physician       Date:  1999-01       Impact factor: 3.275

3.  Early-onset breast cancer: what do we know about the risk factors?: A Countercurrents Series.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

4.  Effect of breast self-examination techniques on the risk of death from breast cancer.

Authors:  B J Harvey; A B Miller; C J Baines; P N Corey
Journal:  CMAJ       Date:  1997-11-01       Impact factor: 8.262

Review 5.  Hereditary breast cancer. Psychosocial issues and family physicians' role.

Authors:  J C Carroll; R E Heisey; E Warner; V Goel; D R McCready
Journal:  Can Fam Physician       Date:  1999-01       Impact factor: 3.275

Review 6.  Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.

Authors:  E Warner; R E Heisey; V Goel; J C Carroll; D R McCready
Journal:  Can Fam Physician       Date:  1999-01       Impact factor: 3.275

7.  WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.

Authors:  Snigdha Banerjee; Neela Saxena; Krishanu Sengupta; Ossama Tawfik; Matthew S Mayo; Sushanta K Banerjee
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

8.  Do Preferred Risk Formats Lead to Better Understanding? A Multicenter Controlled Trial on Communicating Familial Breast Cancer Risks Using Different Risk Formats.

Authors:  Lidewij Henneman; Christi J van Asperen; Jan C Oosterwijk; Fred H Menko; Liesbeth Claassen; Daniëlle Rm Timmermans
Journal:  Patient Prefer Adherence       Date:  2020-02-19       Impact factor: 2.711

9.  Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling.

Authors:  Caroline F Ockhuysen-Vermey; Lidewij Henneman; Christi J van Asperen; Jan C Oosterwijk; Fred H Menko; Daniëlle R M Timmermans
Journal:  BMC Cancer       Date:  2008-10-03       Impact factor: 4.430

10.  Breast Cancer in Canadian Women.

Authors:  Heather Bryant
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.